Article published in Global University Venturing, 25/02/2025. Read it here.
Universities are coming under increased pressure from big healthcare funders such as the Gates Foundation in the US and the Wellcome Trust in the UK, as well as from national funding bodies, to make sure that when they license their medical discoveries, these agreements include clauses to make the treatments available in low- and middle-income countries.
Several universities in the US already include this in their licenses, while a new European Union-funded programme, IMPAC3T-IP, is encouraging universities to include fair access to their healthcare IP. A group of leading universities in the UK are discussing a similar move.
Read the full article on Global University Venturing here.